Predictions
Invitae Corp
Start price
Target price
Perf. (%)
€3.32
26.08.22
26.08.22
-
26.08.23
26.08.23
-17.03%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp
Start price
Target price
Perf. (%)
€3.50
21.08.22
21.08.22
€1.00
21.08.23
21.08.23
-21.28%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€64.36
10.08.22
10.08.22
-
10.08.23
10.08.23
6.49%
10.08.23
10.08.23
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
10.08.22
10.08.22
-
10.08.23
10.08.23
3.34%
10.08.23
10.08.23
Invitae Corp
Start price
Target price
Perf. (%)
€2.86
12.07.22
12.07.22
€2.10
12.07.23
12.07.23
-54.35%
11.03.23
11.03.23
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€3.48
08.06.22
08.06.22
-
08.06.23
08.06.23
-14.83%
16.04.23
16.04.23
Risky Investment
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€2.81
30.05.22
30.05.22
-
30.05.23
30.05.23
23.85%
08.06.22
08.06.22
Risky Investment
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.22
22.05.22
22.05.22
-
22.05.23
22.05.23
-1.45%
22.05.23
22.05.23
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.42
16.05.22
16.05.22
-
16.05.25
16.05.25
-53.44%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€36.83
03.05.22
03.05.22
€30.00
03.05.23
03.05.23
-38.60%
11.03.23
11.03.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.77
28.04.22
28.04.22
€25.00
28.04.23
28.04.23
19.70%
03.05.22
03.05.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Nektar Therapeutics
Start price
Target price
Perf. (%)
€4.42
19.04.22
19.04.22
-
19.04.23
19.04.23
-2.94%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.86
12.04.22
12.04.22
-
12.04.23
12.04.23
-23.60%
12.04.23
12.04.23
Novocure Ltd
Start price
Target price
Perf. (%)
€64.20
16.03.22
16.03.22
€68.00
16.03.23
16.03.23
-6.99%
17.03.23
17.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Teladoc Health Inc
Start price
Target price
Perf. (%)
€54.20
16.03.22
16.03.22
€65.00
16.03.23
16.03.23
-43.24%
28.04.22
28.04.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€46.58
14.03.22
14.03.22
€35.00
14.03.23
14.03.23
16.36%
16.03.22
16.03.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.74
20.02.22
20.02.22
€30.00
20.03.22
20.03.22
2.76%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€6.22
06.02.22
06.02.22
-
06.02.23
06.02.23
-15.28%
20.02.22
20.02.22
Risky Investment